These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 20667608

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation.
    Saleh MN, Raisch KP, Stackhouse MA, Grizzle WE, Bonner JA, Mayo MS, Kim HG, Meredith RF, Wheeler RH, Buchsbaum DJ.
    Cancer Biother Radiopharm; 1999 Dec; 14(6):451-63. PubMed ID: 10850332
    [Abstract] [Full Text] [Related]

  • 5. Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts.
    Gurtner K, Ebert N, Pfitzmann D, Eicheler W, Zips D, Baumann M, Krause M.
    Radiat Oncol; 2014 Dec 02; 9():261. PubMed ID: 25444177
    [Abstract] [Full Text] [Related]

  • 6. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
    Matar P, Rojo F, Cassia R, Moreno-Bueno G, Di Cosimo S, Tabernero J, Guzmán M, Rodriguez S, Arribas J, Palacios J, Baselga J.
    Clin Cancer Res; 2004 Oct 01; 10(19):6487-501. PubMed ID: 15475436
    [Abstract] [Full Text] [Related]

  • 7. Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay.
    Ingargiola M, Runge R, Heldt JM, Freudenberg R, Steinbach J, Cordes N, Baumann M, Kotzerke J, Brockhoff G, Kunz-Schughart LA.
    Int J Cancer; 2014 Aug 15; 135(4):968-80. PubMed ID: 24615356
    [Abstract] [Full Text] [Related]

  • 8. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
    Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh JA, Quennet V, Walenta S, Mueller-Klieser W, Baumann M.
    Radiother Oncol; 2006 Nov 15; 81(2):122-9. PubMed ID: 16956683
    [Abstract] [Full Text] [Related]

  • 9. Tumour-infiltrating CD11b+ myelomonocytes and response to fractionated irradiation of human squamous cell carcinoma (hSCC) xenografts.
    Zaleska K, Bruechner K, Baumann M, Zips D, Yaromina A.
    Radiother Oncol; 2011 Oct 15; 101(1):80-5. PubMed ID: 21724288
    [Abstract] [Full Text] [Related]

  • 10. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D, Helfrich B, Chan DC, Ciardiello F, Zhao L, Franklin W, Barón AE, Zeng C, Johnson TK, Bunn PA.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [Abstract] [Full Text] [Related]

  • 11. Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.
    Skvortsova I, Skvortsov S, Raju U, Stasyk T, Riesterer O, Schottdorf EM, Popper BA, Schiestl B, Eichberger P, Debbage P, Neher A, Bonn GK, Huber LA, Milas L, Lukas P.
    Radiother Oncol; 2010 Jul 15; 96(1):108-15. PubMed ID: 20451273
    [Abstract] [Full Text] [Related]

  • 12. Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression.
    Gurtner K, Deuse Y, Bütof R, Schaal K, Eicheler W, Oertel R, Grenman R, Thames H, Yaromina A, Baumann M, Krause M.
    Radiother Oncol; 2011 Jun 15; 99(3):323-30. PubMed ID: 21665304
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice.
    Eicheler W, Krause M, Hessel F, Zips D, Baumann M.
    Radiother Oncol; 2005 Aug 15; 76(2):151-6. PubMed ID: 16026875
    [Abstract] [Full Text] [Related]

  • 14. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM.
    Cancer Res; 2004 Aug 01; 64(15):5355-62. PubMed ID: 15289342
    [Abstract] [Full Text] [Related]

  • 15. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
    Schütze C, Dörfler A, Eicheler W, Zips D, Hering S, Solca F, Baumann M, Krause M.
    Strahlenther Onkol; 2007 May 01; 183(5):256-64. PubMed ID: 17497097
    [Abstract] [Full Text] [Related]

  • 16. C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.
    Nakata E, Hunter N, Mason K, Fan Z, Ang KK, Milas L.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1163-73. PubMed ID: 15234052
    [Abstract] [Full Text] [Related]

  • 17. Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.
    Yamazaki M, Yamashita Y, Kubo N, Yashiro M, Ohira M, Ako E, Tanaka H, Muguruma K, Sawada T, Hirakawa K.
    Oncol Rep; 2012 Jul 15; 28(1):49-54. PubMed ID: 22562413
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro.
    Eke I, Ingargiola M, Förster C, Kunz-Schughart LA, Baumann M, Runge R, Freudenberg R, Kotzerke J, Heldt JM, Pietzsch HJ, Steinbach J, Cordes N.
    Int J Radiat Biol; 2014 Aug 15; 90(8):678-86. PubMed ID: 24597752
    [Abstract] [Full Text] [Related]

  • 19. [EGFR-blockade by antibody Cetuximab inhibits the growth of human gastric cancer xenograft in nude mice and its possible mechanism].
    Zhang J, Ji J, Yuan F, Ma T, Ye ZB, Yu YY, Liu BY, Zhu ZG.
    Zhonghua Zhong Liu Za Zhi; 2009 Feb 15; 31(2):85-9. PubMed ID: 19538880
    [Abstract] [Full Text] [Related]

  • 20. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
    Zips D, Eicheler W, Brüchner K, Jackisch T, Geyer P, Petersen C, van der Kogel AJ, Baumann M.
    Int J Radiat Biol; 2001 Dec 15; 77(12):1185-93. PubMed ID: 11747543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.